Saputo Reports Broad-Based Growth Across All Segments in Q1 2027
The Canadian dairy giant posted an 8% increase in adjusted EBITDA as investments in high-protein ingredients and operational efficiency drive margin expansion.
Strong Start to Fiscal Year
Saputo Inc. reported consolidated adjusted EBITDA growth of close to 8%, reaching $427 million in its first quarter of fiscal 2027, with margins expanding to 9.7% from 9.1% in the prior year (earnings call, 2026-08-07). The Canadian dairy company, with a market capitalization of approximately $11 billion, delivered earnings growth across all four operating sectors.
"All four of our operating sectors delivered earnings growth versus the prior year, supported by commercial momentum, higher volumes from expanded ingredients capacity and the operational efficiencies flowing through from our prior capital investments," said Carl Colizza, President and CEO (earnings call, 2026-08-07).
Revenue totaled $4.4 billion, up 1.5%, driven by volume growth in high-protein ingredients, higher domestic selling prices, and increased dairy ingredient market prices. Adjusted earnings per share increased 17% to $0.49, benefiting from stronger earnings and share repurchases (earnings call, 2026-08-07).
Ingredients Platform Delivers
The company's investments in high-protein ingredients capacity showed clear returns. CFO Maxime Therrien noted that the U.S. segment posted adjusted EBITDA of $181 million, up 6%, with margins expanding to 8.6% (earnings call, 2026-08-07). The performance was driven by higher sales volumes, favorable product mix, and increased market prices for high-protein ingredients.
"The capacity we have added over the last several years is being absorbed by customer demand, driving increased production of higher protein ingredients and supporting earnings growth," Colizza said (earnings call, 2026-08-07).
Regional Performance
Canada delivered particularly strong results with revenues up 6% to $1.4 billion and adjusted EBITDA of $175 million, up 3%. The segment benefited from higher sales volumes across cheese, dairy foods, and milk, along with "stronger sale of value-added beverages and culture products supported by consumer demand for high-protein offering" (earnings call, 2026-08-07).
Europe showed notable margin improvement, with adjusted EBITDA rising 10% to $33 million despite an 11% revenue decline. Margins expanded to 11.7% from 9.5%, supported by favorable product mix and operational efficiencies (earnings call, 2026-08-07).
The International segment posted adjusted EBITDA of $38 million, up 46%, with margins at 6% (earnings call, 2026-08-07).
Portfolio Reshaping and Capital Allocation
Saputo closed the sale of an 80% interest in its Argentina dairy division for $710 million in proceeds during the quarter. The company also announced an agreement to sell its stake in the Danone Saputo Dairy Australia joint venture for approximately $253 million, subject to regulatory approval (earnings call, 2026-08-07).
The company returned approximately $380 million to shareholders through share repurchases of $300 million and dividends of $80 million. The Board approved a 5% dividend increase from $0.20 to $0.21 per share, effective with the September payment (earnings call, 2026-08-07).
Net debt to adjusted EBITDA stood at 1.47x, well below the company's long-term target of 2.25x (earnings call, 2026-08-07). Subject to TSX approval, Saputo intends to increase its normal course issuer bid to approximately 24 million shares.
MarginX data shows Saputo is expected to report Q2 2027 results on November 5, 2026.
This article was generated by MarginX from the earnings call on 2026-08-07. It is not investment advice.